Natural compounds with antimicrobial and antiviral effect and nanocarriers used for their transportation

D Stan, AM Enciu, AL Mateescu, AC Ion… - Frontiers in …, 2021 - frontiersin.org
Due to the increasing prevalence of life-threatening bacterial, fungal and viral infections and
the ability of these human pathogens to develop resistance to current treatment strategies …

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors

SA Amin, S Banerjee, K Ghosh, S Gayen… - Bioorganic & medicinal …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) brutally perils physical and
mental health worldwide. Unavailability of effective anti-viral drug rendering global threat of …

Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic

FR Bhuiyan, S Howlader, T Raihan, M Hasan - Frontiers in medicine, 2020 - frontiersin.org
COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …

Natural products' role against COVID-19

A da Silva Antonio, LSM Wiedemann… - RSC advances, 2020 - pubs.rsc.org
COVID-19 is a viral disease caused by a new severe acute respiratory syndrome (SARS-
CoV-2), which has quickly resulted in a pandemic. As a great threat to global public health …

Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin …

C Mouffouk, S Mouffouk, S Mouffouk… - European journal of …, 2021 - Elsevier
The novel coronavirus outbreak (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) represents the actual greatest global public health crisis. The …

Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility

C Vicidomini, V Roviello, GN Roviello - Molecules, 2021 - mdpi.com
The current COronaVIrus Disease 19 (COVID-19) pandemic caused by SARS-CoV-2
infection is enormously affecting the worldwide health and economy. In the wait for an …

Quinolines-Based SARS-CoV-2 3CLpro and RdRp Inhibitors and Spike-RBD-ACE2 Inhibitor for Drug-Repurposing Against COVID-19: An in silico Analysis

R Alexpandi, JF De Mesquita, SK Pandian… - Frontiers in …, 2020 - frontiersin.org
The novel coronavirus SARS-CoV-2 disease “COVID-19” emerged in China and rapidly
spread to other countries; due to its rapid worldwide spread, the WHO has declared this as a …

Contributions of human ACE2 and TMPRSS2 in determining host–pathogen interaction of COVID-19

S Senapati, P Banerjee, S Bhagavatula… - Journal of genetics, 2021 - Springer
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is at present an
emerging global public health crisis. Angiotensin converting enzyme 2 (ACE2) and trans …

Medicinal plants, phytochemicals, and herbs to combat viral pathogens including SARS-CoV-2

AV Anand, B Balamuralikrishnan, M Kaviya, K Bharathi… - Molecules, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome corona virus-2 (SARS-CoV-2), is the most important health issue, internationally …

Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in …

MI Khan, ZA Khan, MH Baig, I Ahmad, AEA Farouk… - PLoS …, 2020 - journals.plos.org
A novel severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) causing
COVID-19 pandemic in humans, recently emerged and has exported in more than 200 …